Minimal residual disease (MRD) continues to be a central focus at the AACR meeting. The small numbers of cancer cells that ...
A graphic of a purple and magenta Cas9 protein, which is a somewhat round, but uneven, ball, bound to a yellow and orange ...
Harbinger Health, a biotechnology company pioneering cancer resolution, today announced the presentation of multiple posters on Harbinger's platform and approach at the American Association for Cancer ...
Purpose-built small language models provide a practical solution for government organizations to operationalize AI with the ...
New algorithms support Illumina TruPath™ Genome: v4.5 introdues analytical support for TruPath, leveraging algorithmic advances to resolve 15 highly homologous, medically-relevant genes for rare ...
Attendees at the AACR Annual Meeting 2026 can meet with ClearNote Health's scientific leaders, including newly appointed Chief Medical Officer, Jeffrey Venstrom, MD. At booth 3448 ...
Anna Reinert, MD, discusses emerging developments in adenomyosis treatment that have the potential to improve clinical ...
New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more ...
Forensic casework laboratories will now have access to NimaGen’s IDseek ® massively parallel sequencing (MPS) kit portfolio through Promega Corporation, following a distribution agreement announced ...
A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...
Autism Spectrum Disorder now affects approximately 1 in 31 children in the United States, according to the CDC’s 2025 ADDM ...
UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results